$1.48
-0.03-1.99%
At close: -
$1.47
-0.01-0.68%
After Hours: 9:29 AM EDT
Comments
Loading...
Sonnet BioTherapeutics (SONN) Forecast
NewsEarningsSonnet BioTherapeutics (SONN) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestSonnet BioTherapeutics (NASDAQ:SONN) Stock Quotes, Forecast and News Summary
Sonnet BioTherapeutics Stock (NASDAQ: SONN) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Sonnet BioTherapeutics (SONN) stock?
You can purchase shares of Sonnet BioTherapeutics (NASDAQ:SONN) through any online brokerage.
Who are Sonnet BioTherapeutics (SONN) competitors?
Other companies in Sonnet BioTherapeutics’s space includes: Syros Pharmaceuticals (NASDAQ:SYRS), Tharimmune (NASDAQ:THAR), Quoin Pharmaceuticals (NASDAQ:QNRX), Synaptogenix (NASDAQ:SNPX) and Evaxion Biotech (NASDAQ:EVAX).
What is the forecast, or price target, for Sonnet BioTherapeutics (SONN) stock?
Sonnet BioTherapeutics has a consensus price target of $8.54.
What is the current price for Sonnet BioTherapeutics (SONN)?
The stock price for Sonnet BioTherapeutics (NASDAQ: SONN) is $1.47 last updated December 30, 2024 at 9:29 AM EST.
Does Sonnet BioTherapeutics (SONN) pay a dividend?
There are no upcoming dividends for Sonnet BioTherapeutics.
When is Sonnet BioTherapeutics (NASDAQ:SONN) reporting earnings?
Sonnet BioTherapeutics’s Q1 earnings are confirmed for Wednesday, February 12, 2025.
Is Sonnet BioTherapeutics (SONN) going to split?
There is no upcoming split for Sonnet BioTherapeutics.
What sector and industry does Sonnet BioTherapeutics (SONN) operate in?
Sonnet BioTherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.